BAUSCH + LOMB CORP (BLCO) Stock Fundamental Analysis
USA - NYSE:BLCO - CA0717051076 - Common Stock
15.1 USD
+0.1 (+0.67%)
15.1 USD
0 (0%)
Overall BLCO gets a fundamental rating of 2 out of 10. We evaluated BLCO against 188 industry peers in the Health Care Equipment & Supplies industry. BLCO has a medium profitability rating, but doesn't score so well on its financial health evaluation. BLCO has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year BLCO was profitable.
BLCO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BLCO reported negative net income in multiple years.
BLCO had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
BLCO's Return On Assets of -2.21% is fine compared to the rest of the industry. BLCO outperforms 69.15% of its industry peers.
BLCO has a better Return On Equity (-4.74%) than 69.68% of its industry peers.
With a decent Return On Invested Capital value of 0.76%, BLCO is doing good in the industry, outperforming 66.49% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BLCO is significantly below the industry average of 8.98%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.21% | ||
| ROE | -4.74% | ||
| ROIC | 0.76% |
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.59%
ROIC(5y)1.92%
1.3 Margins
The Operating Margin of BLCO (2.31%) is better than 67.55% of its industry peers.
BLCO's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 59.45%, BLCO perfoms like the industry average, outperforming 59.04% of the companies in the same industry.
In the last couple of years the Gross Margin of BLCO has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.31% | ||
| PM (TTM) | N/A | ||
| GM | 59.45% |
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BLCO is destroying value.
Compared to 1 year ago, BLCO has more shares outstanding
BLCO has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BLCO has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.82, we must say that BLCO is in the distress zone and has some risk of bankruptcy.
BLCO's Altman-Z score of 0.82 is in line compared to the rest of the industry. BLCO outperforms 52.66% of its industry peers.
A Debt/Equity ratio of 0.77 indicates that BLCO is somewhat dependend on debt financing.
BLCO's Debt to Equity ratio of 0.77 is on the low side compared to the rest of the industry. BLCO is outperformed by 72.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.82 |
ROIC/WACC0.1
WACC7.47%
2.3 Liquidity
A Current Ratio of 1.51 indicates that BLCO should not have too much problems paying its short term obligations.
With a Current ratio value of 1.51, BLCO is not doing good in the industry: 76.06% of the companies in the same industry are doing better.
BLCO has a Quick Ratio of 1.51. This is a bad value and indicates that BLCO is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.98, BLCO is not doing good in the industry: 79.26% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.51 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
The earnings per share for BLCO have decreased strongly by -29.51% in the last year.
The Revenue has been growing slightly by 6.23% in the past year.
The Revenue has been growing slightly by 4.87% on average over the past years.
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%
3.2 Future
The Earnings Per Share is expected to grow by 24.18% on average over the next years. This is a very strong growth
Based on estimates for the next years, BLCO will show a small growth in Revenue. The Revenue will grow by 4.94% on average per year.
EPS Next Y-11.58%
EPS Next 2Y12.93%
EPS Next 3Y18.02%
EPS Next 5Y24.18%
Revenue Next Year6.52%
Revenue Next 2Y6.16%
Revenue Next 3Y5.72%
Revenue Next 5Y4.94%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 35.12 indicates a quite expensive valuation of BLCO.
BLCO's Price/Earnings ratio is a bit cheaper when compared to the industry. BLCO is cheaper than 70.74% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.51. BLCO is valued slightly more expensive when compared to this.
Based on the Price/Forward Earnings ratio of 19.10, the valuation of BLCO can be described as rather expensive.
Based on the Price/Forward Earnings ratio, BLCO is valued a bit cheaper than 79.79% of the companies in the same industry.
BLCO is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.98, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.12 | ||
| Fwd PE | 19.1 |
4.2 Price Multiples
76.60% of the companies in the same industry are more expensive than BLCO, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 18.39 |
4.3 Compensation for Growth
A more expensive valuation may be justified as BLCO's earnings are expected to grow with 18.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.93%
EPS Next 3Y18.02%
5. Dividend
5.1 Amount
No dividends for BLCO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
15.1
+0.1 (+0.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners11.05%
Inst Owner Change7.26%
Ins Owners0.44%
Ins Owner Change9.85%
Market Cap5.35B
Revenue(TTM)4.98B
Net Income(TTM)-305.00M
Analysts72
Price Target15.43 (2.19%)
Short Float %8.31%
Short Ratio6.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.13%
Min EPS beat(2)1.79%
Max EPS beat(2)8.47%
EPS beat(4)3
Avg EPS beat(4)-86.5%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)6
Avg EPS beat(8)-37.66%
EPS beat(12)9
Avg EPS beat(12)-24.06%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.15%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.39%
Revenue beat(4)0
Avg Revenue beat(4)-1.38%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.16%
Revenue beat(8)3
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)0.82%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.53%
PT rev (3m)-1.34%
EPS NQ rev (1m)-1.56%
EPS NQ rev (3m)-1.55%
EPS NY rev (1m)1.62%
EPS NY rev (3m)11.23%
Revenue NQ rev (1m)-0.63%
Revenue NQ rev (3m)-0.56%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)0.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.12 | ||
| Fwd PE | 19.1 | ||
| P/S | 1.07 | ||
| P/FCF | N/A | ||
| P/OCF | 31.64 | ||
| P/B | 0.83 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.39 |
EPS(TTM)0.43
EY2.85%
EPS(NY)0.79
Fwd EY5.24%
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)0.48
OCFY3.16%
SpS14.05
BVpS18.16
TBVpS-4.39
PEG (NY)N/A
PEG (5Y)N/A
Graham Number13.25
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.21% | ||
| ROE | -4.74% | ||
| ROCE | 0.96% | ||
| ROIC | 0.76% | ||
| ROICexc | 0.78% | ||
| ROICexgc | 2.5% | ||
| OM | 2.31% | ||
| PM (TTM) | N/A | ||
| GM | 59.45% | ||
| FCFM | N/A |
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.59%
ROIC(5y)1.92%
ROICexc(3y)1.64%
ROICexc(5y)1.97%
ROICexgc(3y)5.47%
ROICexgc(5y)6.76%
ROCE(3y)2.02%
ROCE(5y)2.43%
ROICexgc growth 3Y-21.86%
ROICexgc growth 5Y-17.06%
ROICexc growth 3Y-20.45%
ROICexc growth 5Y-15.79%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
F-Score4
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.06 | ||
| Cap/Depr | 85.28% | ||
| Cap/Sales | 7.34% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 31.12% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.51 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 0.82 |
F-Score4
WACC7.47%
ROIC/WACC0.1
Cap/Depr(3y)53.43%
Cap/Depr(5y)52.81%
Cap/Sales(3y)5.03%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
EPS Next Y-11.58%
EPS Next 2Y12.93%
EPS Next 3Y18.02%
EPS Next 5Y24.18%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%
Revenue Next Year6.52%
Revenue Next 2Y6.16%
Revenue Next 3Y5.72%
Revenue Next 5Y4.94%
EBIT growth 1Y-39.47%
EBIT growth 3Y-15.55%
EBIT growth 5Y-13.93%
EBIT Next Year45.28%
EBIT Next 3Y21.2%
EBIT Next 5Y15.82%
FCF growth 1Y-880%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.07%
OCF growth 3Y-35.71%
OCF growth 5Y-21.91%
BAUSCH + LOMB CORP / BLCO FAQ
What is the fundamental rating for BLCO stock?
ChartMill assigns a fundamental rating of 2 / 10 to BLCO.
What is the valuation status for BLCO stock?
ChartMill assigns a valuation rating of 2 / 10 to BAUSCH + LOMB CORP (BLCO). This can be considered as Overvalued.
Can you provide the profitability details for BAUSCH + LOMB CORP?
BAUSCH + LOMB CORP (BLCO) has a profitability rating of 4 / 10.
What is the valuation of BAUSCH + LOMB CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BAUSCH + LOMB CORP (BLCO) is 35.12 and the Price/Book (PB) ratio is 0.83.
Can you provide the financial health for BLCO stock?
The financial health rating of BAUSCH + LOMB CORP (BLCO) is 1 / 10.